Published in J Rheumatol on March 24, 1980
Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis (1987) 1.53
Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Dis (1993) 1.16
Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing. J Clin Invest (1985) 0.92
Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity. Ann Rheum Dis (1986) 0.92
Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice. Immunology (1998) 0.81
Low-dose procainamide: low risk of complications with long-term use. J Natl Med Assoc (1983) 0.75
The choroid plexus in systemic lupus erythematosus. Ann Intern Med (1972) 2.69
Antinuclear antibodies in mice. II. Transmission with spleen cells; inhibition or prevention with thymus or spleen cells. Immunology (1969) 1.76
Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med (1989) 1.75
Antinuclear antibodies: diagnostic significance and methods. Arthritis Rheum (1967) 1.64
Still disease in adults. A cause of prolonged undiagnosed fever. JAMA (1973) 1.59
Living with lupus: a prospective pan-Canadian study. J Rheumatol (2001) 1.56
Immunohematologic characteristics of infection-associated cerebral infarction. Stroke (1991) 1.55
Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet (1999) 1.50
Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44
Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei. Science (1968) 1.41
Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum (1988) 1.41
The elusive search for geographic clusters of systemic lupus erythematosus. Critical review. Arthritis Rheum (1995) 1.38
Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke (1996) 1.38
Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum (1983) 1.35
Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum (1998) 1.24
Antiviral antibodies in rheumatoid synovial fluid and cryoprecipitates. Clin Exp Immunol (1974) 1.20
CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis Rheum (1990) 1.19
Interleukin 1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS). Clin Immunol Immunopathol (1987) 1.19
Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest (1985) 1.18
Immunoglobulin G subclass of human antinuclear antibodies. Clin Exp Immunol (1970) 1.17
Plant thorn synovitis. Arthritis Rheum (1977) 1.17
Pulmonary involvement in adult-onset Still's disease. Curr Opin Pulm Med (1999) 1.17
Anti-nuclear antibodies in mice. I. Influence of age and possible genetic factors on spontaneous and induced responses. J Immunol (1968) 1.13
Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum (1984) 1.12
Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun (2001) 1.11
Septic arthritis in systemic lupus erythematosus. J Rheumatol (1975) 1.10
Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun (2009) 1.07
Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus. Dig Dis Sci (1982) 1.07
Histocompatibility (HL-A) antigens and lymphocytotoxic antibodies in systemic lupus erythematosus (SLE). Arthritis Rheum (1974) 1.07
Immunological studies in familial primary biliary cirrhosis. Gastroenterology (1976) 1.04
Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol (2000) 1.03
IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis. Clin Exp Immunol (1983) 1.02
Ductular carcinoma of the breast: serum antibodies to tumor-associated antigens. Cancer (1979) 1.02
Procainamide-induced serologic changes in asymptomatic patients. Arthritis Rheum (1969) 1.02
Herpes gestationis in association with a hydatidiform mole. Immunopathologic studies. Arch Dermatol (1981) 1.00
Cardiac compression in rheumatoid pericarditis. Semin Arthritis Rheum (1990) 0.98
Immunologic responses in patients with lepromatous leprosy. Arch Dermatol (1976) 0.98
T lymphocyte subsets in systemic lupus erythematosus. Correlations with corticosteroid therapy and disease activity. Arthritis Rheum (1983) 0.96
Interleukin-1 production by mononuclear cells from patients with scleroderma. Clin Exp Immunol (1985) 0.95
Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res (1999) 0.95
Lupus foot: deforming arthropathy of the feet in systemic lupus erythematosus. J Rheumatol (1984) 0.94
Pulmonary involvement in primary biliary cirrhosis. J Clin Gastroenterol (1987) 0.94
Cryoglobulinaemia in patients with infectious endocarditis. Clin Exp Immunol (1975) 0.94
Low molecular weight GTP-binding proteins in HL-60 granulocytes. Assessment of the role of ARF and of a 50-kDa cytosolic protein in phospholipase D activation. J Biol Chem (1995) 0.94
IgG antibodies to double-stranded DNA in systemic lupus erythematosus sera. Independent variation of complement fixing activity and total antibody content. Arthritis Rheum (1979) 0.93
Polyarteritis nodosa-like vasculitis in human immunodeficiency virus infection. J Rheumatol (1995) 0.93
Increased frequency of HLA-DRW2 in SLE. Lancet (1979) 0.92
Spontaneous Autoimmunity in Mice: Antibodies to Nucleoprotein in Strain A/J. Science (1964) 0.92
Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med (2000) 0.92
Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum (1991) 0.91
Studies of an interleukin 1 inhibitor: characterization and clinical significance. Clin Exp Immunol (1986) 0.91
Immunopathological studies on the cutaneous lesions in sarcoidosis. Br J Dermatol (1977) 0.91
Squamous cell carcinoma of the skin in black patients with discoid lupus erythematosus. J Rheumatol (1987) 0.91
Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum (1993) 0.90
Rheumatoid nodules and rheumatoid granulomas in systemic lupus erythematosus. JAMA (1972) 0.90
A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum (1990) 0.90
The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus. J Rheumatol (1993) 0.88
Increase in fibronectin in the deep dermis of involved skin in progressive systemic sclerosis. Arthritis Rheum (1979) 0.88
Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta. Lupus (1999) 0.88
Interstitial lung disease and cryoglobulinemia in polymyositis. J Rheumatol (1991) 0.87
Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis. Clin Exp Immunol (1978) 0.87
Experimental arthritis in man and rabbit dependent upon serum anti-immunoglobulin factors. Ann N Y Acad Sci (1969) 0.87
Budd-Chiari syndrome associated with antiphospholipid antibodies in a child: report of a case and review of the literature. J Rheumatol (1994) 0.87
Autoimmunity in thermal injury: occurrence of rheumatoid factors, antinuclear antibodies and antiepithelial antibodies. Clin Exp Immunol (1971) 0.87
Changes in circulating monocytes in patients with progressive systemic sclerosis. J Rheumatol (1987) 0.86
Double-stranded DNA: an antigen of unique significance. J Lab Clin Med (1978) 0.85
Renal damage in systemic lupus erythematosus with normal renal function. J Rheumatol (1976) 0.85
Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma. Clin Exp Immunol (1986) 0.85
Small airways function in nonsmokers with rheumatoid arthritis. Arthritis Rheum (1984) 0.84
Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus. Clin Exp Immunol (1988) 0.84
Soft-tissue calcification in systemic lupus erythematosus. Arch Dermatol (1975) 0.83
Myocarditis in mixed connective tissue disease: clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum (1986) 0.82
Lucio's phenomenon: an immune complex deposition syndrome in lepromatous leprosy. Clin Immunol Immunopathol (1978) 0.82
Inhibition of mammalian cytotoxic cells by phosphatidylcholine and its analogue. Nature (1975) 0.82
Clinical and biological characteristics of Ureaplasma urealyticum induced polyarthritis in a patient with common variable hypogammaglobulinaemia. Ann Rheum Dis (1991) 0.82
Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study. Semin Arthritis Rheum (1986) 0.81
Serratia arthritis in heroin users. J Bone Joint Surg Am (1975) 0.81
Arthropathy associated with factor XIII deficiency. Arthritis Rheum (1986) 0.81
Current knowledge and concepts of the relationship of malignancy, autoimmunity, and immunologic disease. Ann N Y Acad Sci (1974) 0.81
Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis. Breast Cancer Res Treat (1985) 0.81
The induction of synovitis in the normal rabbit with Fab. A possible experimental model of rheumatoid arthritis. Am J Pathol (1969) 0.80
Immunoglobulin deposits in skin in systemic lupus erythematosus. Arthritis Rheum (1975) 0.80
In vitro activity of anti-DNA antibodies from SLE patients in antibody-dependent cell-mediated cytotoxicity. Int Arch Allergy Appl Immunol (1976) 0.80
Management of acute malignant large-bowel obstruction with self-expanding metal stent. Surg Endosc (2007) 0.80